A Phase 2, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of JTT-851 in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2013
At a glance
- Drugs JTT 851 (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.